Medizone Home
×
International Pharma Supplies Analytical Samples for Biosimilar Development Unlicensed Medicines Supplies Comparator Sourcing for clinical trials

International Pharma Supplies

We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on German products.

Analytical Samples for Biosimilar Development

We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach.

Unlicensed Medicines Supplies

We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies.

Comparator Sourcing for clinical trials

We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources.

Epirus to sell CHO platform and biosimilar IP to Polpharma

As part of a cost-savings restructure, Epirus is selling the assets from its $14m acquisition of Bioceros last September to its biosimilars partner Polpharma. Last year , Epirus Biopharmaceuticals paid $14m ...

Comparator Sourcing – Clinical Trials – Medizone

Medizone campaign: Opening up new dimensions in comparator sourcing for clinical trials. Being a pioneer means having a vision. Medizone as a strategic comparator sourcing partner for clinical trials and ...

FDA approves Inflectra, a biosimilar to Remicade

The U.S. Food and Drug Administration approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the ...

EMA accepts Sandoz’s pegfilgrastim submission

Sandoz, announced that EMA has accepted their Marketing Authorization Application for its biosimilar to Amgen’s EU-licensed Neulasta (pegfilgrastim) – a long-acting recombinant human granulocyte ...